wayForward (acquired by DarioHealth Corp.)

wayForward (acquired by DarioHealth Corp.)

wayForward (Psyinnovations Inc.) is now a part of DarioHealth Corp. – a leading global digital therapeutics company that is transforming chronic condition management. Dario's AI-powered, digital therapeutic solutions go beyond just managing diseases, offering personalized experiences and evidence-based interventions. With a focus on behavioral health, Dario provides intuitive digital tools and coaching to drive sustainable outcomes.

The world-leading Dario Blood Glucose Monitoring System has received regulatory clearance in the US and Europe, as well as approvals in Canada, Australia, and other key markets. DarioHealth is rapidly expanding into new geographic markets and chronic conditions, exemplifying its performance-based approach to improving users' health.

Founded in 2016, DarioHealth is headquartered in the United States. Its last investment of $2.20M in a Seed Round took place on 01 June 2020, with participation from Epsilon Health Investors and Leo Capital Ventures.

With a slogan of "Making behavioral health and emotional wellness accessible to all," wayForward's integration into DarioHealth's portfolio represents an exciting convergence of digital health solutions, positioning both companies at the forefront of the Health Care industry.